Regular articleExtensive nuclear sphere generation in the human Alzheimer's brain
Introduction
Central hallmarks of Alzheimer's disease (AD) are the amyloid precursor protein (APP)-related amyloidogenic plaques, mainly consisting of the cleavage fragment beta-amyloid, which impairs synaptic plasticity and behavior (for review [Selkoe, 2008]). In addition, the intracellular APP domain (AICD), which contains a highly conserved binding motif to proteins with phosphotyrosine binding domain, has been related to cell toxicity (Chang et al., 2006, Kögel et al., 2012, Wang et al., 2014). AICD is preferentially generated through the amyloidogenic cleavage of APP (Goodger et al., 2009). AICD toxicity has been linked to the phosphotyrosine binding domain–containing protein FE65—an adapter protein that has the ability to shuttle from the cellular periphery to the nucleus (Kimberly et al., 2001, Kinoshita et al., 2002, Lee et al., 2008). The 60-kD FE65 isoform (p60FE65) is enriched in neurons and has been suggested to contribute to AD (Domingues et al., 2011). The profound relationship between APP and FE65 becomes evident following the comparison of the APP family (Herms et al., 2004) to the FE65/FE65L1 (Guénette et al., 2006) knockdown mouse model, in view of the fact that as corresponding mice present a highly similar cortical dysplasia phenotype in both models. The third major player for the APP/FE65 signal transduction pathway, which may play a crucial role in neurodegeneration, is the histone acetyltransferase TIP60 (Cao and Südhof, 2001).
Since the identification of this pathway, numerous controversial studies about its impact or irrelevance have been conducted, triggered by interesting findings, for example, subsequently regulated target genes such as APP, LRP, NEP, or GSK3β (Barbagallo et al., 2010, Ceglia et al., 2015, Grimm et al., 2011, Kim et al., 2003, Liu et al., 2007, Müller et al., 2007), and challenged by opposing findings (Bergman et al., 2003, Hébert et al., 2006, Waldron et al., 2008). Apart from this controversy, it emerged that the APP FE65 interaction is strongly regulated, and that FE65 has the capacity to enter the nucleus to set up nuclear complexes, which were later termed nuclear spheres (Loosse et al., 2016, Müller et al., 2013, Schrötter et al., 2013). Similar structures have been described before (Muresan and Muresan, 2004) and the binding of the adapter protein FE65 to APP was shown to be affected by the phosphorylation of threonine 668 residue in APP (APP T668) (Ando et al., 2001, Nakaya and Suzuki, 2006). Thus, the post-translational phosphorylation of APP at this specific residue is capable of modifying the generation of nuclear spheres. Moreover, AICD release from the cell membrane, which results from increased γ-secretase-dependent APP processing, may modulate nuclear sphere generation as a consequence of its nuclear signaling capacity (Gersbacher et al., 2013, Goodger et al., 2009). Presently still very limited, our current knowledge regarding the function of nuclear spheres can be subdivided into 3 different aspects: DNA repair, gene expression, and cell cycle reentry.
The functional impact of nuclear spheres for DNA repair is predominantly derived from the role of the histone acetyltransferase TIP60, as mutated TIP60 is ineffective in DNA double-strand break repair (Ikura et al., 2000). Of note, the same work reported a DNA helicase activity in the investigated TIP60 complex, which might correspond to the BLM helicase that has been recently identified as a component of nuclear spheres (Schrötter et al., 2013). Finally, FE65 was shown to be fundamental for TIP60-derived DNA damage (Stante et al., 2009).
Gene expression changes have been discussed since a transcriptionally active complex consisting of AICD, FE65, and TIP60 was discovered (Cao and Südhof, 2001). As mentioned previously, these changes are still a matter of debate due to highly controversial findings (Waldron et al., 2008). Notably, a recent work demonstrates the importance of nuclear sphere generation for gene expression changes, whereas expression of single-sphere components was proved to be ineffective (Loosse et al., 2016). The question if AICD does or does not contribute in nuclear spheres remains a controversial issue (Loosse et al., 2016, Schrötter et al., 2013).
The potential function of nuclear spheres in submitting a cell division signal in neurons mainly arises from deregulated proliferation and cell cycle protein expression in FE65 knockdown cells (Schrötter et al., 2013). The cell cycle reentry hypothesis is particularly interesting in view of the fact that APP itself had already been associated with DNA synthesis in neurons, which resulted in cell death (for review, see [Neve and McPhie, 2007]). Moreover, cell cycle deregulation in neurons is one of the earliest changes that can be observed in the AD brain (for review, see [Moh et al., 2011]).
The 3 different functional aspects of nuclear sphere generation listed previously may be correlated. This hypothesis is supported by the finding that expression of FE65 modulates cell cycle progression by regulating the expression of the thymidylate synthase (Bruni et al., 2002). It became apparent that our knowledge about nuclear spheres regarding their generation, function, and regulation is extremely limited and the hypotheses stated previously need to be studied in more detail. The existence of these complexes in the human brain and the potential changes in a diseased brain compared to a healthy one had not yet been identified. The present study sheds light on the relevance that nuclear spheres appear to have for the human brain and for Alzheimer's disease as yet another APP-dependent potentially toxic protein aggregate.
Section snippets
Plasmid constructs
pCDNA3 Flag Jnk1a2 and pCDNA3 Flag MKK7B2Jnk3a2 were a gift from Roger Davis (Addgene plasmid # 15,741 and # 19,729). HA GSK3 beta wt pcDNA3 was a gift from Jim Woodgett (Addgene plasmid # 14,753). Cdc2 was a gift from Sander van den Heuvel (Addgene plasmid # 1886). pCAX APP AENATA was a gift from Dennis Selkoe & Tracy Young-Pearse (Addgene plasmid # 30,144). 896 pcDNA3 T7 Akt1 was a gift from William Sellers (Addgene plasmid # 9003). PCDNA3 APP (T668A) was a kind gift from Toshiharu Suzuki,
Nuclear spheres can be identified in the human brain
Nuclear spheres consist of FE65, TIP60, BLM, as well as potentially other currently unknown proteins. There are a few functional experiments, mainly in cell culture models, suggesting the toxic character of these nuclear aggregates; however, their potential relevance for the human brain had not yet been demonstrated. To close this gap, we applied immunohistological (IH) staining for the nuclear sphere components BLM and TIP60 in human frontal cortex brain samples. Using a commercially available
Discussion
Amyloidogenic cleavage of APP and the subsequent aggregation of Aβ oligomers is a central biochemical hallmark of Alzheimer's disease. In the present study, we demonstrate a yet unknown hallmark of AD, which is likewise APP related. So called nuclear spheres, structures containing proteins FE65, TIP60, and BLM, were identified in the human brain with the aid of an extended immunostaining protocol for TIP60 and BLM. Notably, all approaches to stain FE65, the central adapter protein that connects
Conclusions
Our study suggests that nuclear spheres are a second APP-derived central hallmark of AD in addition to the toxic β-amyloid. Phosphorylation modifications of APP residue T668 modulate the generation of nuclear spheres, which may cause degeneration of neurons and putatively contributes to dementia. The present knowledge for the generation and function of nuclear spheres is limited, but the finding of extensive nuclear sphere generation in the human Alzheimer brain reveals new starting points for
Disclosure statement
The authors declare that they have no conflict of interests.
Acknowledgements
This work was funded by FoRUM (Forschungsförderung Ruhr-Universität Bochum Medizinische Fakultät) F800-2014, MERCUR (Mercator Research Center Ruhr) AN-2013-0024, and DFG (Deutsche Forschungsgemeinschaft) MU3525/3. The authors are grateful to Prof. Werner Paulus (Institute of Neuropathology, University Hospital Münster, Pottkamp 2, 48129, Münster, Germany) for providing the human brain samples. The authors are grateful to Dagmar Groß (Division of Human Biology and Human Genetics, University of
References (52)
- et al.
Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid
J. Biol. Chem.
(2001) - et al.
APP intracellular domain formation and unaltered signaling in the presence of familial Alzheimer's disease mutations
Exp. Cell Res.
(2003) - et al.
Fe65, a ligand of the Alzheimer's beta-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression
J. Biol. Chem.
(2002) - et al.
Membrane tethering of APP c-terminal fragments is a prerequisite for T668 phosphorylation preventing nuclear sphere generation
Cell Signal
(2016) - et al.
JNK regulates APP cleavage and degradation in a model of Alzheimer's disease
Neurobiol. Dis.
(2009) - et al.
Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis
Cell
(2000) - et al.
The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner
J. Biol. Chem.
(2001) - et al.
The APP intracellular domain (AICD) potentiates ER stress-induced apoptosis
Neurobiol. Aging
(2012) - et al.
Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factories
Neurobiol. Aging
(2010) - et al.
Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1
Neuron
(2007)
Nuclear spheres modulate the expression of BEST1 and GADD45G
Cell Signal
Membrane-microdomain localization of amyloid β-precursor protein (APP) C-terminal fragments is regulated by phosphorylation of the cytoplasmic Thr668 residue
J. Biol. Chem.
A ternary complex consisting of AICD, FE65, and TIP60 down-regulates Stathmin1
Biochim. Biophys. Acta
Dysfunction of amyloid precursor protein signaling in neurons leads to DNA synthesis and apoptosis
Biochim. Biophys. Acta
c-Jun N-terminal kinase regulates soluble Aβ oligomers and cognitive impairment in AD mouse model
J. Biol. Chem.
Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior
Behav. Brain Res.
Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism
Neurobiol. Dis.
Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription
Exp. Cell Res.
In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3beta
J. Neurochem.
Tyr(682) in the intracellular domain of APP regulates amyloidogenic APP processing in vivo
PLoS One
A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60
Science
APP intracellular domain-WAVE1 pathway reduces amyloid-β production
Nat. Med.
Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration
Mol. Cell Biol
Identification and characterization of a neuronal enriched novel transcript encoding the previously described p60Fe65 isoform
J. Neurochem.
Turnover of amyloid precursor protein family members determines their nuclear signaling capability
PLoS One
Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway
J. Cell Sci
Cited by (0)
- 1
These authors contributed equally.